Page 68 - Bio Engineering Approaches to Cancer Diagnosis and Treatment

66 CHAPTER 3 Immune assay assisted cancer diagnostic

[32] J.M. Schwenk, U. Igel, M. Neiman, H. Langen, C. Becker, A. Bjartell, F. Ponten, F.
Wiklund, H. Gronberg, P. Nilsson, et al. Toward next generation plasma profiling via
heat-induced epitope retrieval and array-based assays, Mol. Cell. Proteomics 9 (11)
(2010) 2497–2507.
[33] J.C. Miller, H. Zhou, J. Kwekel, R. Cavallo, J. Burke, E.B. Butler, et al. Antibody micro-
array profiling of human prostate cancer sera: antibody screening and identification of
potential biomarkers, Proteomics 3 (1) (2003) 56–63.
[34] S. Darmanis, T. Cui, K. Drobin, S.C. Li, K. Oberg, P. Nilsson, J.M. Schwenk, V. Gi-
andomenico, Identification of candidate serum proteins for classifying well-differentiated
small intestinal neuroendocrine tumors, PLoS One 8 (11) (2013) e81712.
[35] S.A. Khan, D. Reddy, S. Gupta, Global histone post-translational modifications and
cancer: biomarkers for diagnosis, prognosis and treatment?, World J. Biol. Chem. 6 (4)
(2015) 333–345.
[36] Z. Chen, T. Dodig-Crnkovic´, J.M. Schwenk, S.C. Tao, Current applications of antibody
microarrays, Clin. Proteomics 15 (2018) 7, doi: 10.1186/s12014-018-9184-2.
[37] P. Delfani, L. Dexlin Mellby, M. Nordström, A. Holmér, M. Ohlsson, C.A.K. Borrebaeck,
et al. Technical advances of the recombinant antibody microarray technology platform
for clinical immunoproteomics, PLoS One 11 (7) (2016) e0159138.
[38] B. Bohunicky, S.A. Mousa, Biosensors: the new wave in cancer diagnosis, Nanotechnol.
Sci. Appl. 4 (2010) 1–10.
[39] F.S. Felix, L. Angnes, Electrochemical immunosensors—a powerful tool for analytical
applications, Biosens. Bioelectron. 102 (2018) 470–478.
[40] V.S.A. Jayanthi, A.B. Das, U. Saxena, Recent advances in biosensor development for the
detection of cancer biomarkers, Biosens. Bioelectron. 91 (2017) 15–23.
[41] Su, Li, et al. Development of novel piezoelectric biosensor using pzt ceramic resonator
for detection of cancer markers. Biosensors and biodetection. Humana Press, New York,
NY, 2017, pp. 277–291.
[42] S. Sharma, H. Byrne, R.J. O’Kennedy, Antibodies and antibody-derived analytical bio-
sensors, Essays Biochem. 60 (1) (2016) 9–18.
[43] E. Spain, S. Gilgunn, S. Sharma, K. Adamson, E. Carthy, R. O’Kennedy, R.J. Forster,
Detection of prostate specific antigen based on electrocatalytic platinum nanoparticles
conjugated to a recombinant scFv antibody, Biosens. Bioelectron. 77 (2016) 759–766.
[44] E. Arkan, R. Saber, Z. Karimi, M. Shamsipur, A novel antibody–antigen based impedi-
metric immunosensor for low level detection of HER2 in serum samples of breast cancer
patients via modification of a gold nanoparticles decorated multiwall carbon nanotube-
ionic liquid electrode, Anal. Chim. Acta 874 (2015) 66–74.
[45] C. Cristea, A. Florea, R. Galatus, E. Bodoki, R. Sandulescu, D. Moga, D. Petreus, Inno-
vative immunosensors for early stage cancer diagnosis and therapy monitoring, in: The
International Conference on Health Informatics, Springer, Cham, 2014, pp. 47–50.
[46] J.F. Rusling, G.W. Bishop, N. Doan, F. Papadimitrakopoulos, Nanomaterials and bioma-
terials in electrochemical arrays for protein detection, J. Mater. Chem. B 2 (1) (2014)doi:
10.1039/C3TB21323D.
[47] J.P. O’connor, E.O. Aboagye, J.E. Adams, H.J. Aerts, S.F. Barrington, A.J. Beer, D.L.
Buckley, Imaging biomarker roadmap for cancer studies, Nat. Rev. Clin. Oncol. 14 (3)
(2017) 169.
[48] T. Hussain, Q.T. Nguyen, Molecular imaging for cancer diagnosis and surgery, Adv.
Drug Deliv. Rev. 66 (2013) 90–100.